1. Schweitzer A., Horn J., Mikolajczyk R.T., Krause G., Ott J.J. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 // Lancet. 2015. Vol. 386, No. 10003. Р. 1546-1555. https://doi.org/10.1016/S0140-6736(15)61412-X.
2. Suesstrunk J., Djongali F. B. Hepatitis B virus prevalence in rural areas in south-west Chad // Tropical Doctor. 2017. Vol. 47, No. 4. Р. 374-377. https://doi.org/10.1177/0049475517699718.
3. Zampino R., Boemio A., Sagnelli C., Alessio L., Adinolfi L. E., Sagnelli E., Coppola N. Hepatitis B virus burden in developing countries // World J. Gastroenterol. 2015. Vol. 21, No. 42. Р. 11941-1953. https://doi.org/10.3748/wjg.v21.i42.11941.
4. Kramvis A., Kew M.C. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes // Hepatol Res. 2007. Vol. 37. Р. S9-S19. https://doi.org/10.1111/j.1872-034X.2007.00098.x.
5. Wurie I.M., Wurie A.T., Gevao S.M. Sero-prevalence of hepatitis B virus among middle to high socio-economic antenatal population in Sierra Leone // West Afr. J. Med. 2005. Vol. 24, No. 1. Р. 18-20. https://doi.org/10.4314/wajm.v24i1.28156
6. Bigna J.J., Amougou M.A., Asangbeh S.L., Kenne A.M., Noumegni S.R.N., Ngo-Malabo E.T., Noubiap J.J. Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis // BMJ Open. 2017. Vol. 7. e015298. https://doi.org/10.1136/bmjopen-2016-015298.
7. Sadoh A.E., Sadoh W.E. Serological markers of hepatitis B infection in infants presenting for their first immunization // Niger. J. Paeadiatr. 2013. Vol. 40. Р. 248-253.
8. Shimakawa Y., Bottomley C., Njie R., Mendy M. The association between maternal hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of hepatitis B e antigenaemia in Gambian children // BMC Public Health. 2014. Vol. 14. Р. 532. https://doi.org/10.1186/1471-2458-14-532.
9. Ladep N.G., Lesi O.A., Mark P., Lemoine M., Onyekwere C., Afihene M., Crossey M.M., Taylor-Robinson S.D. Problem of hepatocellular carcinoma in West Africa // World J. Hepatol. 2014. Vol. 6, No. 11. Р. 783-792. https://doi.org/10.4254/wjh.v6.i11.783.
10. Raimondo G., Locarnini S., Pollicino T., Levrero M., Zoulim F. Anna S. Lok, Taormina Workshop on Occult HBV Infection Faculty Members. Update of the statements on biology and clinical impact of occult hepatitis B virus infection // J. Hepatol. 2019. Vol. 71, No. 2. Р. 397-408. https://doi.org/10.1016/j.jhep.2019.03.034.
11. Kew M.C., Welschinger R., Viana R. Occult hepatitis B virus infection in Southern African blacks with hepatocellular carcinoma // J. Gastroenterol. Hepatol. 2008. Vol. 23, No. 9. Р. 1426-1430. https://doi.org/10.1111/j.1440-1746.2008.05481.x.
12. Kramvis A. Molecular characteristics and clinical relevance of African genotypes and subgenotypes of hepatitis B virus // S. Afr. Med. J. 2018. Vol. 108, No.8b. Р. 17-21. https://doi.org/10.7196/SAMJ.2018.v108i8b.13495.
13. Stasi C., Silvestri C., Voller F.Emerging Trends in Epidemiology of Hepatitis B Virus Infection // J. Clin. Transl. Hepatol. 2017. Vol. 5, No. 3. Р. 272-276. https://doi.org/10.14218/JCTH.2017.00010.
14. Mokaya J., McNaughton A.L., Hadley M.J., Beloukas A., Geretti A.M., Goedhals D., Matthews P.C. A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action // PLoS Negl. Trop. Dis. 2018. Vol. 12, No. 8. e0006629. https://doi.org/10.1371/journal.pntd.0006629.
15. Xue Y., Wang M.J., Yang Z.T., Yu D.M., Han Y., Huang D., Zhang D.H., Zhang X.X. Clinical features and viral quasispecies characteristics associated with infection by the hepatitis B virus G145R immune escape mutant // Emerg. Microbes Infect. 2017. Vol. 6, No. 3. e15. https://doi.org/10.1038/emi.2017.2.
16. Yll M., Cortese M.F., Guerrero-Murillo M., Orriols G., Gregori J., Casillas R., González C., Sopena S., Godoy C., Vila M., Tabernero D., Quer J., Rando A., Lopez-Martinez R., Esteban R., Riveiro-Barciela M., Buti M., Rodríguez-Frías F. Conservation and variability of hepatitis B core at different chronic hepatitis stages // World J. Gastroenterol. 2020. Vol. 26, No. 20. Р. 2584-2598. https://doi.org/10.3748/wjg.v26.i20.2584.
17. Ingasia L.A.O., Kostaki E.G., Paraskevis D., Kramvis A. Global and regional dispersal patterns of hepatitis B virus genotype E from and in Africa: A full-genome molecular analysis // PLoS One. 2020. Vol. 15, No. 10. Р. e0240375. https://doi.org/10.1371/journal.pone.0240375.
18. Diallo D., Diallo K., Diallo A., Diallo M., Wann T., Doumbouya A., Sow O., Baldé Y., Dillo A. Epidemiological, Clinical and Biological Characteristics of Patients with Chronic Hepatitis B Infection Followed-Up at the University Hospital of Conakry, Guinea // Open J. Gastroenterology. 2020. Vol. 10. Р. 256-265. https://doi.org/10.4236/ojgas.2020.1010025.
19. Garmiri P., Loua A., Haba N., Candotti D., Allain J.P. Deletions and recombinations in the core region of hepatitis B virus genotype E strains from asymptomatic blood donors in Guinea, west Africa // J. Gen. Virol. 2009. Vol. 90, Pt. 10. Р. 2442-2451. https://doi.org/10.1099/vir.0.012013-0.
20. Останкова Ю.В., Семенов А.В., Тотолян Арег А. Выявление вируса гепатита В в плазме крови при низкой вирусной нагрузке // Клиническая лабораторная диагностика. 2019. Т. 64, № 10. С. 635-640. [Ostankova Yu.V., Semenov A.V., Totolian Areg A. Hepatitis B virus identification in a blood plasma at a low viral load. Klinicheskaya Laboratornaya Diagnostika (Russian Clinical Laboratory Diagnostics). 2019. Vol. 64, No. 10. Р. 635-640 (In Russ.)] https://doi.org/10.18821/0869-2084-2019-64-10-635-640.
21. Щемелев А.Н., Останкова Ю.В., Зуева Е.Б., Boumbaly S., Balde T.A., Семенов А.В. Характеристика вируса гепатита B и вируса иммунодефицита человека среди пациентов с коинфекцией ВИЧ/ВГВ из Гвинейской Республики // Проблемы особо опасных инфекций. 2019. № 3. С. 118-124. [Shchemelev A.N., Ostankova Yu.V., Zueva E.B., Boumbaly S., Balde T.A., Semenov A.V. Characterization of Hepatitis B Virus and Human Immunodeficiency Virus among HIV/HBV Co-Infected Patients from the Republic of Guinea. Problems of Particularly Dangerous Infections. 2019, No. 3, рр. 118-124 (In Russ.)]. https://doi.org/10.21055/0370-1069-2019-3-118-124.
22. Colagrossi L., Hermans L.E., Salpini R., Di Carlo D., Pas S.D., Alvarez M., Ben-Ari Z., Boland G., Bruzzone B., Coppola N., Seguin-Devaux C., Dyda T., Garcia F., Kaiser R., Köse S., Krarup H., Lazarevic I., Lunar M.M., Maylin S., Micheli V., Mor O., Paraschiv S., Paraskevis D., Poljak M., Puchhammer-Stöckl E., Simon F., Stanojevic M., Stene-Johansen K., Tihic N., Trimoulet P., Verheyen J., Vince A., Lepej S.Z., Weis N., Yalcinkaya T., Boucher C.A.B., Wensing A.M.J., Perno C.F., Svicher V.; HEPVIR working group of the European Society for translational antiviral research (ESAR). Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe // BMC Infect. Dis. 2018. Vol. 18, No. 1. Р. 251. https://doi.org/10.1186/s12879-018-3161-2.
23. Magoro T., Gachara G., Mavhandu L., Lum E., Kimbi H.K., Ndip R.N., Bessong P. Serologic and genotypic characterization of hepatitis B virus in HIV-1 infected patients from South West and Littoral Regions of Cameroon // Virol. J. 2016. Vol. 13, No. 1. Р. 178. https://doi.org/10.1186/s12985-016-0636-x.
24. Cerva C., Maffongelli G., Svicher V., Salpini R., Colagrossi L., Battisti A., Mariotti B., Cerretti R., Cudillo L., Sarmati L. Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal // BMC Infect. Dis. 2017. Vol. 17. Р. 566. https://doi.org/10.1186/s12879-017-2672-6.
25. Malagnino V., Salpini R., Maffongelli G., Battisti A., Fabeni L., Piermatteo L., Colagrossi L., Fini V, Ricciardi A., Sarrecchia C., Perno C.F., Andreoni M., Svicher V., Sarmati L. High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance // PLoS One. 2018. Vol. 13, No. 3. Р. e0195045. https://doi.org/10.1371/journal.pone.0195045.